ArticleDermatology and therapy2022

A Retrospective Real-World Study of the Effectiveness and Tolerability of Tildrakizumab in UK Adults with Moderate-to-Severe Chronic Plaque Psoriasis.

Gabrielle Becher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.